Tradipitant in the Treatment of Gastroparesis: Vanda Presents Clinical Trial Results at DDW 2019
Vanda Pharmaceuticals Inc. (VNDA)
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-irhome
Company Research
Source: PR Newswire
WASHINGTON, May 22, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VANDA) (Nasdaq: VNDA) today announced the results of the Phase II study of tradipitant in gastroparesis were presented at Digestive Disease Week® (DDW) 2019 in San Diego, CA. For more information on DDW 2019, please refer to https://ddw.org/home.About VandaVanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com. Investor Contact:Jim KellyExecutive Vice President & Chief Financial OfficerVanda Pharmaceuticals Inc.(202) 734-3428jim.kelly@vandapharma.comMedia Contacts:AJ Jones IIBurson Cohn & Wolfe (BCW)1110 Vermont Avenue, NW, Suite 1200Washington, D.C. 20005202-530-0400pr@vandapharma.comElizabeth Van EveryBurson Cohn & Wolfe (BCW)230 Park Avenue South New York, NY 10003 212-614-3881 pr@vandapharma.com View original
Show less
Read more
Impact Snapshot
Event Time:
VNDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNDA alerts
High impacting Vanda Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
VNDA
News
- Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up [Yahoo! Finance]Yahoo! Finance
- Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know [Yahoo! Finance]Yahoo! Finance
- SINT, ATNF and RETO among mid-day movers [Seeking Alpha]Seeking Alpha
- Why Vanda Pharmaceuticals Stock Is Skyrocketing Today [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan [Yahoo! Finance]Yahoo! Finance
VNDA
Earnings
- 2/7/24 - Beat
VNDA
Analyst Actions
- 2/9/24 - TheStreet
VNDA
Sec Filings
- 4/17/24 - Form 8-A12B
- 4/17/24 - Form 8-K
- 4/3/24 - Form 8-K
- VNDA's page on the SEC website